Chronic inflammatory diseases of the central nervous system (CNS) generally have a grave impact on the quality of life of the people concerned.
Although past research has already made great progress in this area, the triggers and causes of this disease group, which also includes multiple sclerosis, have not been clearly identified yet. Among the suspects, two factors stand out: An increased susceptibility of the central nervous system to external attacks and a malfunctioning immune system.
Damage to nerve cells and a defective immune system
Previously, it was not fully understood to what extent these two factors influence each other. Now, researchers of the University of Würzburg have succeeded in shedding some light on this question. The lead researchers of this study were the medical scientist Heinz Wiendl, head of the clinical research group for multiple sclerosis and neuroimmunology, and the neurobiologist Rudolf Martini, head of the Würzburg study group for developmental neurobiology, at the Department of Neurology of the University of Würzburg. They have now published the result of their research in the American Journal of Pathology.
The researchers had to consider three variables in their study: Mice suffering from a disease that is similar to multiple sclerosis; genetic modifications causing damage to the myelin sheath of the nerve cells - which is a kind of insulation layer; and an immune system that does not work properly. "The question was how a predetermined genetic modification of the myelin - in combination with or without the dysregulation of the immune system - would affect the inflammation of the central nervous system," explains Heinz Wiendl.
One factor alone is not sufficient
The result: If both factors - myelin damage and defective immune system - are present, the inflammatory response in the area of the central nervous system intensifies, leading to increased tissue damage. In contrast, dysfunctional immune cells by themselves do not cause any damage. "If these two genetic modifications come together in mice suffering from an experimental CNS inflammation, this causes an earlier onset and aggravated course of the disease," says Heinz Wiendl. The scientists were able to show that in these cases an increased quantity of immune cells penetrates into the CNS, where they release pro-inflammatory mediators. At the same time, the indicators of nerve cell damage were most clearly visible here.
Significance to humans
Translated to humans, this means: "Genetically determined modifications of the myelin formation or genetically determined dysregulations of the immune system as separate factors do not necessarily cause a disease manifestation," explains Heinz Wiendl. But if these two factors come together and an inflammatory response is directed against the CNS on this basis, the inflammation progresses more violently with significantly more tissue damage than it would without these "predisposing" factors. According to the two scientists, it can be concluded from these findings that a combination of various disease-promoting aspects influences the onset of the disease or the intensity of relapses in the case of multiple sclerosis as well.
Accelerated Course of Experimental Autoimmune Encephalomyelitis in PD-1-Deficient Central Nervous System Myelin Mutants. Antje Kroner, Nicholas Schwab, Chi Wang Ip, Sonja Ortler, Kerstin Göbel,Klaus-Armin Nave,Mathias Mäurer,Rudolf Martini and Heinz Wiendl. The American Journal of Pathology, Vol. 174, No. 6, June 2009, DOI: 10.2353/ajpath.2009.081012Contact information:
Gunnar Bartsch | idw
New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia
New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
18.08.2017 | Life Sciences
18.08.2017 | Physics and Astronomy
18.08.2017 | Materials Sciences